ArticleJournal of experimental & clinical cancer research : CR2018

Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.

Yifan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.